AbbVie Inc. (ABBV)
AbbVie Inc. EPS
| Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $2.9 | $2.6 | $2.1 | $3.4 | $2.6 | $1.1 | $3.2 | $3.7 | $3.3 | $3.7 | $5.3 | $2.7 | $6.5 | $6.7 | $2.7 |
AbbVie Inc. (ABBV) EPS comparison analysis
ABBV key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is AbbVie Inc.'s EPS?
As of today, AbbVie Inc.'s last 12-month EPS is $2.9, based on the financial report for Sep 30, 2024 (Q3 2024).
2) What is AbbVie Inc.'s EPS growth rate?
Over the last year, AbbVie Inc.'s EPS growth was (21.3%). The average annual EPS growth rates for AbbVie Inc. have been 0.2% over the past three years, 5.7% over the past five years.
3) Is AbbVie Inc.'s EPS growth rate Good?
Over the last year, AbbVie Inc.'s EPS growth was (21.3%), which is lower than industry growth of (0.2%). It indicates that AbbVie Inc.'s EPS growth is Bad.